The ICS fully acknowledges the serious complications and significant harm that some patients have experienced from the use of Surgical Mesh in treating stress urinary incontinence and pelvic organ prolapse. We recognise the decisions of several high profile court rulings and enquiries around the world, the recent changes that have seen several mesh products withdrawn from market, and presently the United Kingdom Independent Medicines and Medical Devices Safety Review (IMMDS) released their review on July 8th 2020.
We will be taking all of this into consideration and the ICS will update their position statement, with high priority, on the use of mesh in pelvic organ prolapse and stress urinary incontinence procedures.
Thank you for your patience during this time of change.
IMMDS Report 2020